Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 26, 2015 Filed Sep 29, 2015 21:36 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
Tax withholdingCommon shares without par value | 1,526 | $40.86 | $62,352.36 |
DisclosureSEC source: 0001179110-15-013392 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,789 Read SEC document |
| August 18, 2015 Filed Aug 20, 2015 21:18 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 300 | $50.48 | $15,142.50 |
DisclosureSEC source: 0001179110-15-012422 · edgar.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,601 Read SEC document |
| August 18, 2015 Filed Aug 20, 2015 21:18 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 1,300 | $50.47 | $65,613.60 |
DisclosureSEC source: 0001179110-15-012422 · edgar.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,901 Read SEC document |
| August 18, 2015 Filed Aug 20, 2015 21:18 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 1,000 | $50.47 | $50,470.00 |
DisclosureSEC source: 0001179110-15-012422 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,201 Read SEC document |
| August 18, 2015 Filed Aug 20, 2015 21:18 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 100 | $50.46 | $5,046.20 |
DisclosureSEC source: 0001179110-15-012422 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,201 Read SEC document |
| August 18, 2015 Filed Aug 20, 2015 21:18 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 10,396 | $50.46 | $524,582.16 |
DisclosureSEC source: 0001179110-15-012422 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,301 Read SEC document |
| August 11, 2015 Filed Aug 13, 2015 21:02 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 41,500 | $0.00 Strike: $21.22 | $0.00 |
DisclosureSEC source: 0001179110-15-012082 · edgar.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 41,500 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 11, 2015 Filed Aug 13, 2015 21:02 UTC |
Fussell Stephen RExecutive Vice President
|
Tax withholdingCommon shares without par value | 28,404 | $50.66 | $1,438,946.64 |
DisclosureSEC source: 0001179110-15-012082 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,697 Read SEC document |
| August 11, 2015 Filed Aug 13, 2015 21:02 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionCommon shares without par value | 41,500 | $21.22 | $880,605.10 |
DisclosureSEC source: 0001179110-15-012082 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2015 Filed Aug 7, 2015 21:08 UTC |
Ford Robert BExecutive Vice President
|
GiftCommon shares without par value | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-011904 · edgar.xml · nonDerivative · entry 2 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Ford Family Trust Disclosed balance after: 49,480 F1 · balance_after: Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust. Read SEC document |
| August 05, 2015 Filed Aug 7, 2015 21:08 UTC |
Ford Robert BExecutive Vice President
|
GiftCommon shares without par value | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-011904 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,426 Read SEC document |
| July 29, 2015 Filed Jul 30, 2015 21:51 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionOption (right to buy) · Derivative | 26,000 | $0.00 Strike: $21.22 | $0.00 |
DisclosureSEC source: 0001179110-15-011567 · edgar.xml · derivative · entry 6 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 26,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 29, 2015 Filed Jul 30, 2015 21:51 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Tax withholdingCommon shares without par value | 17,763 | $50.94 | $904,847.22 |
DisclosureSEC source: 0001179110-15-011567 · edgar.xml · nonDerivative · entry 2 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,685 Read SEC document |
| July 29, 2015 Filed Jul 30, 2015 21:51 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Exercise / conversionCommon shares without par value | 26,000 | $21.22 | $551,704.40 |
DisclosureSEC source: 0001179110-15-011567 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2015 Filed Jul 30, 2015 21:52 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 500 | $50.98 | $25,491.50 |
DisclosureSEC source: 0001179110-15-011569 · edgar.xml · nonDerivative · entry 6 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,194 Read SEC document |
| July 28, 2015 Filed Jul 30, 2015 21:52 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 200 | $50.98 | $10,196.20 |
DisclosureSEC source: 0001179110-15-011569 · edgar.xml · nonDerivative · entry 5 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,694 Read SEC document |
| July 28, 2015 Filed Jul 30, 2015 21:52 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 1,000 | $50.98 | $50,980.00 |
DisclosureSEC source: 0001179110-15-011569 · edgar.xml · nonDerivative · entry 4 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,894 Read SEC document |
| July 28, 2015 Filed Jul 30, 2015 21:52 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 200 | $50.97 | $10,194.20 |
DisclosureSEC source: 0001179110-15-011569 · edgar.xml · nonDerivative · entry 3 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,894 Read SEC document |
| July 28, 2015 Filed Jul 30, 2015 21:52 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 1,000 | $50.97 | $50,970.00 |
DisclosureSEC source: 0001179110-15-011569 · edgar.xml · nonDerivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,094 Read SEC document |
| July 28, 2015 Filed Jul 30, 2015 21:52 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 8,400 | $50.96 | $428,072.40 |
DisclosureSEC source: 0001179110-15-011569 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,094 Read SEC document |
| July 01, 2015 Filed Jul 2, 2015 21:05 UTC |
Ford Robert BExecutive Vice President
|
Tax withholdingCommon shares without par value | 1,682 | $49.08 | $82,552.56 |
DisclosureSEC source: 0001179110-15-010821 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,844 Read SEC document |
| July 01, 2015 Filed Jul 2, 2015 21:07 UTC |
Pavee Jean-YvesSenior Vice President
|
Tax withholdingCommon shares without par value | 2,431 | $49.08 | $119,313.48 |
DisclosureSEC source: 0001179110-15-010823 · edgar.xml · nonDerivative · entry 2 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,251 Read SEC document |
| July 01, 2015 Filed Jul 2, 2015 21:07 UTC |
Pavee Jean-YvesSenior Vice President
|
GrantCommon shares without par value | 6,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-010823 · edgar.xml · nonDerivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,682 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 01, 2015 Filed Jul 2, 2015 21:06 UTC |
Mason Heather LExecutive Vice President
|
Tax withholdingCommon shares without par value | 614 | $49.08 | $30,135.12 |
DisclosureSEC source: 0001179110-15-010822 · edgar.xml · nonDerivative · entry 1 Mason Heather L · CIK 0001432601 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,875 Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 21:04 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 702 | $49.08 Strike: $0.00 | $34,454.16 |
DisclosureSEC source: 0001179110-15-010819 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,777 Underlying: Common shares · 702 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 21:03 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 160 | $49.08 Strike: $0.00 | $7,852.80 |
DisclosureSEC source: 0001179110-15-010817 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,571 Underlying: Common shares · 160 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 21:04 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 672 | $49.08 Strike: $0.00 | $32,981.76 |
DisclosureSEC source: 0001179110-15-010818 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,675 Underlying: Common shares · 672 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 21:05 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 672 | $49.08 Strike: $0.00 | $32,981.76 |
DisclosureSEC source: 0001179110-15-010820 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,621 Underlying: Common shares · 672 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 15, 2015 Filed Jun 16, 2015 22:21 UTC |
Watkin JaredSenior Vice President
|
GrantOption (right to buy) · Derivative | 114,692 | $0.00 Strike: $48.04 | $0.00 |
DisclosureSEC source: 0001179110-15-009924 · edgar.xml · derivative · entry 3 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,692 Underlying: Common shares · 114,692 shares Expires 2025-06-14 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,231 on 06/15/2016, 38,230 on 06/15/2017, and 38,231 on 06/15/2018. Read SEC document |
| June 15, 2015 Filed Jun 16, 2015 22:21 UTC |
Watkin JaredSenior Vice President
|
GrantCommon shares without par value | 11,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-009924 · edgar.xml · nonDerivative · entry 1 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,407 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| June 03, 2015 Filed Jun 5, 2015 22:05 UTC |
Pavee Jean-YvesSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,300 | $0.00 Strike: $26.70 | $0.00 |
DisclosureSEC source: 0001179110-15-009279 · edgar.xml · derivative · entry 9 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,300 shares Expires 2018-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| June 03, 2015 Filed Jun 5, 2015 22:05 UTC |
Pavee Jean-YvesSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,200 | $0.00 Strike: $25.25 | $0.00 |
DisclosureSEC source: 0001179110-15-009279 · edgar.xml · derivative · entry 8 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,200 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| June 03, 2015 Filed Jun 5, 2015 22:05 UTC |
Pavee Jean-YvesSenior Vice President
|
SaleCommon shares without par value | 10,500 | $49.00 | $514,500.00 |
DisclosureSEC source: 0001179110-15-009279 · edgar.xml · nonDerivative · entry 3 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,606 Read SEC document |
| June 03, 2015 Filed Jun 5, 2015 22:05 UTC |
Pavee Jean-YvesSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,300 | $26.70 | $141,495.69 |
DisclosureSEC source: 0001179110-15-009279 · edgar.xml · nonDerivative · entry 2 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2015 Filed Jun 5, 2015 22:05 UTC |
Pavee Jean-YvesSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,200 | $25.25 | $131,279.72 |
DisclosureSEC source: 0001179110-15-009279 · edgar.xml · nonDerivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2015 Filed Jun 3, 2015 21:38 UTC |
YOOR BRIAN BSenior Vice President and CFO
|
GrantOption (right to buy) · Derivative | 81,709 | $0.00 Strike: $48.90 | $0.00 |
DisclosureSEC source: 0001179110-15-009074 · edgar.xml · derivative · entry 3 YOOR BRIAN B · CIK 0001643528 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,709 Underlying: Common shares · 81,709 shares Expires 2025-05-31 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,237 on 6/1/2016, 27,236 on 6/1/2017, and 27,236 on 6/1/2018. Read SEC document |
| June 01, 2015 Filed Jun 3, 2015 21:38 UTC |
YOOR BRIAN BSenior Vice President and CFO
|
GrantCommon shares without par value | 11,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-009074 · edgar.xml · nonDerivative · entry 1 YOOR BRIAN B · CIK 0001643528 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,742 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| June 01, 2015 Filed Jun 3, 2015 21:39 UTC |
LANE ANDREW HSenior Vice President
|
GrantOption (right to buy) · Derivative | 114,692 | $0.00 Strike: $48.90 | $0.00 |
DisclosureSEC source: 0001179110-15-009076 · edgar.xml · derivative · entry 1 LANE ANDREW H · CIK 0001643735 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,692 Underlying: Common shares · 114,692 shares Expires 2025-05-31 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,231 on 6/1/2016, 38,230 on 6/1/2017, and 38,231 on 6/1/2018. Read SEC document |
| June 01, 2015 Filed Jun 3, 2015 21:41 UTC |
Blaser Brian J.Executive Vice President
|
Tax withholdingCommon shares without par value | 838 | $48.60 | $40,726.80 |
DisclosureSEC source: 0001179110-15-009078 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,494 Read SEC document |
| June 01, 2015 Filed Jun 3, 2015 21:40 UTC |
Ford Robert BExecutive Vice President
|
GrantOption (right to buy) · Derivative | 14,423 | $0.00 Strike: $48.90 | $0.00 |
DisclosureSEC source: 0001179110-15-009077 · edgar.xml · derivative · entry 3 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,423 Underlying: Common shares · 14,423 shares Expires 2025-05-31 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,808 on 6/1/2016, 4,807 on 6/1/2017, and 4,808 on 6/1/2018. Read SEC document |
| June 01, 2015 Filed Jun 3, 2015 21:40 UTC |
Ford Robert BExecutive Vice President
|
GrantCommon shares without par value | 2,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-009077 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,526 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| June 01, 2015 Filed Aug 20, 2015 21:19 UTC Amendment |
Ford Robert BExecutive Vice President
|
GrantOption (right to buy) · Derivative | 14,243 | $0.00 Strike: $48.90 | $0.00 |
DisclosureSEC source: 0001179110-15-012424 · edgar.xml · derivative · entry 1 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,243 Underlying: Common shares · 14,243 shares Expires 2025-05-31 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,748 on 6/1/2016, 4,747 on 6/1/2017, and 4,748 on 6/1/2018. F2 · shares: This Form 4/A amends the number of derivative securities acquired on June 1, 2015. F2 · derivative.underlying_shares: This Form 4/A amends the number of derivative securities acquired on June 1, 2015. F2 · balance_after: This Form 4/A amends the number of derivative securities acquired on June 1, 2015. Read SEC document |
| May 01, 2015 Filed May 8, 2015 21:01 UTC |
Ford Robert BSenior Vice President
|
GrantCommon shares without par value | 48,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-007426 · edgar.xml · nonDerivative · entry 2 Ford Robert B · CIK 0001612571 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Ford Family Trust Disclosed balance after: 48,062 F1 · balance_after: Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust. Read SEC document |
| May 01, 2015 Filed May 8, 2015 21:01 UTC |
Ford Robert BSenior Vice President
|
GiftCommon shares without par value | 48,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-007426 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,505 Read SEC document |
| April 28, 2015 Filed Apr 29, 2015 22:22 UTC |
NATH DEEPAK S.Senior Vice President
|
Tax withholdingCommon shares without par value | 144 | $47.49 | $6,838.56 |
DisclosureSEC source: 0001179110-15-006829 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,613 Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 22:23 UTC |
BIRD ROGERSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,821 | $0.00 Strike: $25.25 | $0.00 |
DisclosureSEC source: 0001179110-15-006830 · edgar.xml · derivative · entry 13 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,821 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 22:23 UTC |
BIRD ROGERSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 13,527 | $0.00 Strike: $21.22 | $0.00 |
DisclosureSEC source: 0001179110-15-006830 · edgar.xml · derivative · entry 12 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 13,527 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 22:23 UTC |
BIRD ROGERSenior Vice President
|
SaleCommon shares without par value | 1,334 | $47.58 | $63,471.72 |
DisclosureSEC source: 0001179110-15-006830 · edgar.xml · nonDerivative · entry 11 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,810 Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 22:23 UTC |
BIRD ROGERSenior Vice President
|
SaleCommon shares without par value | 2,866 | $47.57 | $136,335.62 |
DisclosureSEC source: 0001179110-15-006830 · edgar.xml · nonDerivative · entry 10 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,144 Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 22:23 UTC |
BIRD ROGERSenior Vice President
|
SaleCommon shares without par value | 5,400 | $47.56 | $256,824.00 |
DisclosureSEC source: 0001179110-15-006830 · edgar.xml · nonDerivative · entry 9 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,010 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.